asundexian
bayer
['asundexian', 'fxi']
ph2 dose-ranging study of oral asundexian (fxia inhibitor) shows marked fxia inhibition without significantly increased bleeding. no diff in cv outcomes in this study but underpowered for this endpt. #esccongress
Dir of Prev Cardiology @MassGeneralNews | Assoc Prof @harvardmed | Assoc Mem @broadinstitute | Assoc Ed @JAMACardio @ScienceAdvances | Co-Founder @tensixteenbio